SKP2 and lung cancer: Also, the wound healing and transwell assays results demonstrated that over-expression of Skp2 increased lung cancer cell migration in both YF-18 treatment and vehicle control and reversed cell migration inhibition by YF-18 treatment (Figure 5D and 5E).